Wellcome Trust

Wellcome Trust, KU Leuven, Janssen collaborate

Wednesday, September 4, 2013 11:53 AM

Wellcome Trust, Janssen and KU Leuven are collaborating for dengue antiviral drugs. The collaboration will build on an existing three-year drug discovery program at the Rega Institute and the Center for Drug Design and Discovery (CD3) at KU Leuven, supported by a Wellcome Trust Seeding Drug Discovery Award.

More... »

CoCo Therapeutics created to develop new treatments for Alzheimer’s disease

Friday, March 8, 2013 12:08 PM

King’s College London, The Wellcome Trust and Advent Venture Partners have announced the formation of a new U.K. biotechnology company, CoCo Therapeutics, to progress the research of Professor Jonathan Corcoran into the development of new treatments for Alzheimer’s disease.

More... »

Cell Medica secures $26.5M to establish U.S. operations and fund cell therapy development

Monday, July 23, 2012 03:04 PM

Cell Medica, a London-based cell therapeutics company, has secured a $26.5 million equity investment to launch new operations in Texas focusing on cancer immunotherapy and to continue development of its immune reconstitution cell therapies in Europe.

More... »

Wellcome Trust awards Phagenesis $1.5 million for dysphagia treatment

Tuesday, May 22, 2012 10:02 AM

Phagenesis, a U.K. company focused on dysphagia (the inability to swallow), has been awarded $1.5 million from the Wellcome Trust to extend the scope of its dysphagia treatment device, from hospitals into the community.

More... »

Burrill wraps up life sciences industry for Q1 2012

Wednesday, April 4, 2012 03:00 PM

Burrill & Company, a diversified global financial services firm focused on the life sciences industry, has identified more than $2.6 billion in expected funding through nine translational research and early-stage initiatives announced since the end of February.

More... »

1000 Genomes Project data available on Amazon Cloud

Monday, April 2, 2012 02:51 PM

The world's largest set of data on human genetic variation — produced by the international 1000 Genomes Project — is now publicly available on the Amazon Web Services (AWS) cloud, the according to the National Institutes of Health (NIH).

More... »

Emergent receives NIAID grant for TB vaccine

Friday, March 23, 2012 01:06 PM

Emergent BioSolutions has received a multi-year grant from the National Institute of Allergy and Infectious Diseases (NIAID) to advance the development of MVA85A, a candidate vaccine against tuberculosis (TB).

More... »

Wellcome Trust to launch $317 million investment business

Wednesday, March 21, 2012 10:36 AM

The Wellcome Trust’s board of governors has approved the creation of a new business that will invest in emerging businesses and technologies in the healthcare and life sciences sectors.

More... »

Survey aims to capture public attitudes on sharing genomic results

Tuesday, January 31, 2012 02:28 PM

An ethics team from the Wellcome Trust Sanger Institutein Cambridge, U.K., is launching an online survey to capture the views of as many people as possible about how they would like their genetic data handled.

More... »